DEF: CV Sciences, Inc. Announces Annual Meeting of Stockholders to be Held Virtually on June 2, 2025

Sentiment:

Proxy Statement


CV Sciences, Inc. will hold its annual meeting of stockholders virtually on June 2, 2025, to vote on director elections, auditor ratification, executive compensation, and other business matters.

Summary

  • CV Sciences, Inc. will hold its annual meeting of stockholders on June 2, 2025, at 9:00 a.m. Pacific Time, in a virtual format.
  • Stockholders of record as of April 4, 2025, are entitled to vote at the meeting.
  • The meeting's agenda includes the election of three directors, ratification of Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, an advisory vote on executive compensation, and an advisory vote on the frequency of executive compensation votes.
  • The Board of Directors recommends voting FOR the election of the director nominees and FOR all other proposals.
  • As of the record date, April 4, 2025, there were 184,263,663 shares of Common Stock outstanding held by approximately 41 stockholders of record.
  • The company is providing access to proxy materials primarily electronically via the Internet.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, presenting routine corporate governance matters. The tone is neutral and informative, with a clear recommendation from the board. The sentiment is moderately positive due to the forward-looking nature of the meeting and the board's recommendations.

Positives

  • The company is providing a virtual meeting format for a convenient experience for all stockholders.
  • Stockholders have multiple opportunities to submit questions to the Company for the Meeting.
  • The Board recommends voting FOR all proposals.

Future Outlook

The Board intends to consider the outcome of the advisory vote on executive compensation when making future executive compensation decisions.

Management Comments

  • Our Board of Directors has carefully reviewed and considered the foregoing proposals and has concluded that each proposal is in the best interests of the Company and its stockholders.
  • Therefore, our Board of Directors has approved each proposal and recommends that you vote FOR each of the director nominees included in Proposal 1 and FOR all of the other foregoing proposals.

Industry Context

The document does not provide specific industry context beyond the general corporate governance practices related to annual meetings and proxy statements.

Stakeholder Impact

  • Shareholders are directly impacted through their voting rights on key company decisions.
  • Employees are indirectly impacted through the approval of executive compensation and overall corporate governance.

Next Steps

  • Stockholders should review the proxy materials and vote on the proposals.
  • Stockholders can attend the virtual annual meeting on June 2, 2025.
  • The company will announce preliminary voting results at the meeting and publish final results in a Current Report on Form 8-K.

Key Dates

DateDescription
April 4, 2025Record date for determining stockholders entitled to notice of and to vote at the Meeting.
April 15, 2025Date of Notice of Annual Meeting of Stockholders
April 17, 2025Mailing date of the Notice of Internet Availability of Proxy Materials.
June 2, 2025Date of the Annual Meeting of Stockholders.
December 12, 2025Deadline for stockholders to submit proposals for inclusion in the 2026 proxy statement.
April 4, 2026Deadline for stockholders to submit director nominations for the 2026 annual meeting.

Keywords

annual meeting, proxy statement, stockholders, directors, executive compensation, auditor ratification, corporate governance, CV Sciences

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.